According to the World Health Organization data, 1.13 billion people worldwide suffer from arterial hypertension, with only 21% under proper control. Dementia currently negatively affects the quality of life of 55 million people worldwide, with one new case recorded every 3.2 seconds. Analyzing the effects of antihypertensive medications on cognitive function and evaluating protective mechanisms against dementia development is currently considered one of the urgent issues. There is reliable evidence that the effects of antihypertensive medications on cognitive function are related not only to blood pressure reduction but also to independent neuroprotective mechanisms. Angiotensin receptor blockers reduce dementia risk by 12-26% compared to other antihypertensive medications. Calcium channel blockers demonstrate 17% greater neuroprotective effects compared to other drug classes. ARBs and calcium channel blockers possess the best neuroprotective properties and are considered preferable for cognitive function protection. These effects occur independently of blood pressure reduction mechanisms.
| Mualliflar | Атоева, М, Абдуллаева, Г, Юсупова, Х, Ибрагимова, И, Atoeva , Munisa, Abdullaeva , Guzal, Yusupova, Xafiza, Ibragimova, Iroda, Atoeva , Munisa, Abdullaeva , Guzal, Yusupova , Khafiza, Ibragimova , Iroda |
|---|---|
| Jurnal | O‘zbekiston кardiologiyasi |
| Nashr sanasi | 2025-06-30 |
| Jild | 2 |
| Son | 2 |
| Betlar | 169-178 |
| Til | O‘zbek |
| DOI | 10.70626/cardiouz-2025-2-00049 |
DOI: 10.70626/cardiouz-2025-2-00049 · Maqolaning asl sahifasi
sudden cardiac death, ischemic heart disease, ventricular arrhythmias, left ventricular ejection fraction, myocardial scar tissue, coronary artery bypass grafting, risk stratification, secondary prevention, cardiovascular mortality, внезапная сердечная смерть, ишемическая болезнь сердца, желудочковые аритмии, фракция выброса левого желудочка, рубцовая ткань миокарда, аортокоронарное шунтирование, стратификация риска, вторичная профилактика, сердечно-сосудистая смертность, to‘satdan yurak o‘limi, yurak ishemik kasalligi, qorincha aritmiyalari, chap qorincha ejeksiyon fraktsiyasi, miokard chandiq to‘qimasi, koronar arteriya bypass grefti, xavfning tabaqalanishi, ikkilamchi profilaktika, yurak-qon tomir o‘limi
Aim. To evaluate the effectiveness of posterior pericardiotomy in reducing the risk of postoperative supraventricular arrhythmias in patients who underwent off-pump coronary artery bypass grafting. Materials and…
Sudden Cardiac Death (SCD) is one of the most severe and life-threatening manifestations of cardiovascular diseases and is among the leading causes of mortality worldwide. The primary pathogenic factors contributing to…
Aim. To evaluate the clinical effectiveness and safety of the Ross procedure in children with congenital aortic valve disease. The main aim of the study was to determine the physiological and hemodynamic advantages of…
Aim. To study the impact of lipoprotein (a) levels on major cardiovascular events. Materials and methods. We examined the impact of lipoprotein(a) levels on major cardiovascular events based on a review of articles on…
In recent years, researchers have focused on the role of various adipose tissue depots in the development of coronary artery disease (CAD), extending beyond traditional obesity assessments based on body mass index…
Aim. To evaluate the efficacy and safety of the Uzbekistan-manufactured “Sinotech+” stent during primary percutaneous coronary intervention (pPCI) in patients presenting with ST-elevation acute coronary syndrome…
Aim. To evaluate the one-year dynamic effect of complete or incomplete revascularization on left ventricular ejection fraction (LVEF) in patients with a history of myocardial infarction (MI) who have preserved or mildly…
Aim. To assess the features of global staged remodeling of the heart chambers in patients with ischemic chronic heart failure, depending on the degree of left ventricular ejection fraction (LVEF) reduction, using…
This review synthesizes current evidence on early biomarkers of endothelial dysfunction (ED) in cardiovascular disease (CVD), emphasizing their role in diagnosis, prognosis, and management. ED, characterized by reduced…
Aim: Clinical testing of the NeuromedAI Cardio intelligent system, designed to automate routine tasks of cardiologists and improve the quality of medical care; Materials and methods. The study used the NeuromedAI Cardio…